Financings in Brief: Marquette Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Marquette Medical Systems: Shareholder rights plan approved by the firm's board would become effective if a person or group acquired 20% or more of the firm's outstanding stock, Marquette says. Marquette notes it will issue 262,500 shares of its class A common stock to its chairman, Michael Cuhady, in exchange for Cuhady's 26.3 mil. shares of class C common. The move, which will be completed Dec. 23, will make Marquette's class A shares the only class of stock outstanding...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.